Novartis to donate 130M doses of hydroxychloroquine

Friday, 20. March 2020 17:15

Swiss pharmaceutical company Novartis said on Friday it will donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response. The company said that up to 130 million 200 mg doses will be donated by the end of May, including its current stock of 50 million 200 mg doses.

It added that "Novartis Sandoz division will pursue appropriate regulatory authorizations and, upon approval, will work with stakeholders to determine how best to get this medicine to the patients who need it"

According to the statement, this commitment "builds on the previously announced commitments of a USD 20 million Novartis COVID-19 Response Fund, drug discovery collaboration efforts, support of clinical trials for existing Novartis medicines, and the Sandoz commitment to maintain stable prices on a basket of essential medicines that may help in the treatment of COVID-19."

Related Links: Novartis AG
Breaking the News / TF